Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tifovac CL
- Development stage
- Unknown
- Lead developer
- FARVET
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
Tifovac CL is a live-attenuated bacterial vaccine developed by FARVET for the immunization of poultry against Fowl Typhoid, a severe systemic disease caused by *Salmonella enterica* serovar Gallinarum. The vaccine typically utilizes the 9R strain of *Salmonella Gallinarum*, which is a rough strain that has lost its O-antigen but retains the ability to stimulate a robust immune response. By inducing both humoral and cell-mediated immunity, Tifovac CL helps reduce mortality, clinical signs, and the shedding of the pathogen in replacement birds, such as layers and breeders. It is specifically formulated for veterinary use in poultry flocks to control *Salmonella* infections and is currently approved for marketing.
- Brand names
- Tifovac CL
- Other names
- Tifovac CL-FARVET
02
Targets
Salmonella
Beyond the preview
Go deeper on Tifovac CL.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tifovac CL.